Selbyville, Delaware, Oct. 03, 2022 (GLOBE NEWSWIRE) --
The automated cell counter market value is poised to reach USD 9 billion by 2030, according to a new research report by Global Market Insights Inc. Increasing technological advancements in the field as a significant factor propelling the market expansion.
Cognizance of early disease diagnosis to foster demand for coulter counters
Coulter counter segment accounted for over 19% of the market share in 2021 and is set to register a significant CAGR through 2030. The coulter counting approach has a range of benefits, including high sensitivity, orthogonal operating principle, excellent reproducibility, high-resolution size information, and the ability to detect microscopic particles. The extensive utilization of the device for early detection and diagnosis of various infectious diseases such as Nipah virus encephalitis, severe acute respiratory syndrome (SARS), dengue fever, Lyme disease, etc., may accelerate the segment trends.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5352
Quality patient care to help hospitals emerge as a major end-user
Automated cell counter market from hospitals segment held over 25.5% of the business share in 2021 and may record a noticeable valuation by 2030. Hospital settings have advanced medical equipment, trained medical staff, and accessible services, ensuring precise and accurate diagnosis and treatment. The ability of these establishments to accommodate a significant number of patients due to the high budget and financial capacity, coupled with longer patient stay may garner industry revenues.
Browse key industry insights spread across 165 pages with 183 market data tables & 15 figures & charts from the report, “Automated Cell Counter Market Analysis By Product Type (Fluorescence Image-based Cell Counter, Flow Cytometers, Coulter Counter), Application (Blood Cells, Microbial Cells, Cell Lines), End-use (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030”, in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/automated-cell-counter-market
Inflowing medical investments to push LATAM market share
LATAM automated call counter market is projected to record a CAGR of 3.5% during 2022 and 2030. This is attributed to focus among government agencies to manage the disease burden. Also, increasing investments made by public organizations in the healthcare sector will positively sway the industry dynamics in LATAM.
Acquisitions to bolster the strategic landscape
Prominent shareholders in the automated cell counter market include Abbott Laboratories, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc, Danaher (Beckman Coulter Inc. and Radiometer), Sysmex Corporation, NanoEnTek, F. Hoffmann-La Roche Ltd, Olympus Corporation, Agilent Technologies, Inc., and PerkinElmer, Inc.
Browse Our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.Selbyville, Delaware
